Symbicort in Chronic Obstruktive Pulmonary Disease - SYMBIOSE

Study identifier:1312006001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Symbicort in Chronic Obstruktive Pulmonary Disease

Medical condition

Pulmonary Disease, Chronic Obstructive

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

18014

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Feb 2006

Primary Completion Date: 01 Sept 2006

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
1 Patients with COPD treated with budesonide/formoterol	-

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1510&filename=CSR-1312006001.pdf
Download
CSR-1312006001.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Germany Clinical

0049 4103 708 3707

[email protected]

Investigators

Principal Investigator

Kai Richter

Medical Department AstraZeneca Germany